throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`
`Paper No.62
`Entered: January 27, 2022
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`NEW WORLD MEDICAL INC.,
`Petitioner,
`
`v.
`
`MICROSURGICAL TECHNOLOGY, INC.,
`Patent Owner.
`___________
`
`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`___________
`
`Record of Oral Hearing
`Held: January 10, 2022
`_____________
`
`
`
`
`Before JAMES A. TARTAL, JAMES A. WORTH, ROBERT A.
`POLLOCK, RYAN H. FLAX, and DEVON ZASTROW NEWMAN,
`Administrative Patent Judges.
`
`
`
`
`
`
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`
`
`APPEARANCES:
`
`ON BEHALF OF THE PETITIONER:
`
`
`TODD R. TUCKER, ESQ.
`Calfee, Halter & Griswold, LLP
`1405 E. 6th Street
`
`Cleveland, OH 44114
`
`
`
`ON BEHALF OF THE PATENT OWNER:
`
`
`LAWRENCE SUNG, ESQ.
`Wiley Rein, LLP
`Montgomery Building
`2050 M Street, N.W.
`Washington, D.C. 20036
`
`
`
`
`The above-entitled matter came on for hearing on Monday, January
`10, 2022, commencing at 10:00 a.m., EDT, by video/by telephone.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`
`P R O C E E D I N G S
`- - - - -
`JUDGE FLAX: Good morning. This is Judge Flax. We are
`
`here this morning just past 10 a.m. to hear final oral argument in
`one, two, three, four, five IPRs. Those are IPR 2020- 01573
`concerning patent 9,107,729, IPR 2020- 01711 concerning patent
`9,358,155, IPR 2021- 00017 concerning patent 9,820,885, IPR
`2021-00065 concerning patent 10,123,905 and IPR 2021-00066
`concerning patent 9,999,544. You have an enlarged group of
`judges this morning spanning the panels of these various IPRs
`and besides myself with you today are Judges Tartal, Worth,
`Pollock and Zastrow Newman.
`
`The first thing I would like to do is ask you to please stay
`on mute when you're not speaking. I do hear an echo right now
`so probably someone isn’t, if they would mute themselves that
`would stop happening, so it did just stop and I appreciate that.
`Before we begin I do want to thank you all for your flexibility in
`conducting this remote video hearing today. At this point it's not
`an unusual way to conduct hearings. We know that it's not
`optimal and it's probably not what you would like to do and
`hopefully sometime soon in the future we will not have to hold
`hearings this way. Our primary concern here is your right to be
`heard. So if at any time during the proceeding you encounter
`technical or other difficulties that you feel fundamentally
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`3
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`undermine your ability to adequately represent your client,
`please do let us know immediately by contacting the team
`members who provided you with contact information.
`
`Second, as I just noted, when you're not speaking please do
`mute yourself. It will help us have an accurate record and it will
`help to have everyone participate this way. Third, whenever you
`do speak please identify yourself as a speaker. This will help the
`court reporter prepare an accurate transcript even though he
`should have your names associated with your video feeds. And
`fourth we do have the entire record in front of us including your
`demonstratives and your motions and your papers. So when you
`do refer to anything in the hearing, be it a paper or evidence or a
`motion, please identify it by number and page number and after
`you identify it pause just a moment so that you can give us time
`to find it in the record.
`
`That being said each side has agreed to one hour of
`argument today and at our conference call last week we
`discussed that we have motions on evidence that we will hear
`argument on before we get to the final oral argument on the
`merits. So, and we also agreed that that was going to take at
`most a half an hour, so 15 minutes per side. So if the counsel
`could please introduce themselves and get their names entered on
`the record, go ahead and do that now.
`
`MR. TUCKER: Yes, good morning. This is Todd Tucker.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`4
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`I represent the Petitioner New World Medical. With me is Kyle
`Deighan and John Reulbach and also the general counsel/chief
`patent counsel of New World Medical David Klann. I will be the
`only one speaking however, so thank you.
`
`MR. SUNG: Good morning, Your Honors. For Patent
`Owners Microsurgical Technology, Inc., and the Regents of the
`University of California I am Lawrence Sung on behalf of the
`Patent Owners. With me in the room today is Teresa Summers
`and Jasmine Su.
`
`JUDGE FLAX: Great. Thank you very much. One thing
`that I will ask is that when we are all finished today, if counsel
`would stay on the line for a minute after we go off the record in
`case the court reporter has any questions about how to spell
`things or anything that was said during the argument. Okay. So
`moving to the motions. Each side, Patent Owner and Petitioner
`have motions to exclude the others' evidence at trial here. We
`can start with the Petitioner's Motion to Exclude. That's paper
`52 and what I suggest is that you can go ahead and take as much
`time as you want, I guess your 15 minutes to argue it. Each side
`can also take five minutes afterwards to respond to whatever the
`other side had to argue about their motions. So if you want to go
`ahead and begin, Mr. Tucker.
`
`MR. TUCKER: Thank you, Your Honor. First off, may it
`please the Court. The Motion to Exclude that Petitioner's filed
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`5
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`seeks to exclude kind of three areas of the putative expert of
`Patent Owner's declaration and the three areas are his general --
`very likely general opinion when he applies the prior art in view
`of the claim construction to render ultimate opinions of
`anticipation and obviousness. This is despite not being able to
`define what anticipation obviousness was and we'll get into more
`detail (audio interference) foibles and shortcomings he had in his
`deposition. But essentially what I would say in his deposition is
`in my 26 years of doing patent litigation I've never seen an
`expert so willfully unable to answer questions about his own
`declaration which seemingly makes this declaration appear to be
`nothing more than attorney argument. That's the first tranche, so
`that's the ultimate opinion and the paragraphs underlying the
`ultimate opinion which would be paragraphs 87 through 266.
`
`We also seek to exclude paragraphs 56 through 61 where
`despite opining over five paragraphs about statements the U.S.
`Patent Office made in a Notice of Allowance in the '729 patent,
`he testified he had never seen the document before and finally
`the last group paragraphs 40 and 48 is where despite the
`Quintana declaration being struck from this case, Dr. Condon is
`essentially attempting to ba ckdoor that struck declaration into
`the case.
`
`So if the Board would please turn to demonstrative 13 and
`if you're there Patent Owner argues that Dr. Condon is one of
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`6
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`skill in the art --
`JUDGE FLAX: Counsel, are you talking about your
`demonstrative 13?
`MR. TUCKER: Oh, I'm sorry, yes. New World Medical
`Petitioner's demonstrative 13. Now, an issue in this case that
`we're going to see over and over again and hear a lot about today
`is the Patent Owner just tends to throw everything out there.
`They take a straightforward case and they're making it very
`complicated and also it seemed as if there's lots of reimagining
`going on when things don't go their way.
`So in our Motion we clearly point out, and this is the final
`paragraph of his opinion, paragraph 267 where he says he's
`opining on the ultimate issue in this case which is invalidity, are
`things anticipated, are claims obvious. The paragraphs in front
`of it he goes step by step applying the prior art in view of the
`claim construction to the claim limitations to come up with this
`ultimate opinion but Patent Owner reimagines this as hey, he
`didn't do any of this. All he did was discuss shortcomings in the
`prior art. Well, that's clearly not the case. He is clearly being
`offered for the ultimate issues in this case which becomes a
`major problem given what happened at his deposition.
`If you could turn to Petitioner's slide 14. In our paper I
`think we put about 30 some different statements where he's
`unable to defend what he did, unable to answer questions that he
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`7
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`hadn't read things. Patent Owner really doesn't respond to
`almost any of these. They respond to one they claim was taken
`slightly out of context but this deposition was literally death by a
`thousand cuts. We probably could have cited days, you know,
`pages on pages of where he could not answer things and as you'll
`see in my substantive argument, ironically the few times he
`could answer things he tended to support Petitioner's position.
`But let's run through some of the things that make this
`declaration not worthy to come in under Federal Rule of
`Evidence 702 where, you know, 702 it has to be based on
`sufficient data. It has to be applied reliable principles and
`methods to the facts of this IPR and it starts and it's this running
`cavalcade of I didn't read, I didn't know. He said that he merely
`flipped through the '729 patent. He's being offered for the
`ultimate opinion of patentability (audio interference) he just
`flipped through the patent. He didn't drill down on the
`requirements of the '729. He would not be comfortable telling
`you what is required in the patents at issue. He's admitting he
`can't read the claims.
`Critically, and this one is related to paragraphs 56 to 61.
`He was handed the Notice of Allowance from the '729 patent
`where the examiner, the U.S.P.T.O examiner made observations
`about the Lee reference and those observations went unrebutted,
`so they are admitted. He opined from paragraphs 56 to 61 on
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`8
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`this Notice of Allowance. I handed him Exhibit 15 in his
`deposition is the entire Notice of Allowance. He said, "I have
`not seen this before."
`Now, Patent Owner comes up with some argument in their
`opposition that I was trying to trick him and handed it to him and
`it was very cursory, that's not the case. As the record shows, he
`had the entire exhibit. He opined on this exhibit for several
`pages in his declaration but when presented with this he said,
`"I've never seen this before." The '905 he testified, "I don't
`remember the whole thing." The '155 he testified that he didn't
`"analyze it other than to look at the claim language."
`If we carry on to slide 15 of Petitioner's, what you see is he
`testifies he doesn't understand patent claims which is particularly
`troubling here because he is opining on the patentability of these
`claims. This is very troublesome. He testified in I believe it
`was the '544 patent which he was handed and I asked him,
`"Q Is claim 8 a device claim or a method claim?"
`And keep in mind the first three words of claim in that
`patent are a method for, and he said,
`"A I don't know how to classify it -- specifically classify
`claims."
`So the claim he's opining on he can't event tell us if it's to a
`device or a method. Similarly, he said I'm not capable of
`dissecting information on what the claim elements require.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`9
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`
`If you move on to 16, this is where it -- I think this is the
`death knell of his declaration. He was asked what is his
`understanding of obviousness and he said I "would have to say
`no" and "I can't explain it." Yet, he is offering a declaration
`with opinions where he says the claims are nonobvious.
`Similarly, when he was asked what is your understanding of
`anticipation he said, "It's not crystal clear to me." Again, all of
`these passages are virtually unrefuted in the opposition. They
`claim we cherry picked and took things out of context. I'm not
`sure how it could be taken out of context when an expert who's
`been offered to opine on obviousness says I don't have an
`understanding of obviousness. It's very clear that this is just
`attorney argument thinly veiled with a very, very minor veneer
`of expert opinion and this did not stand up to scrutiny when
`cross-examined.
`Now, turning to paragraphs 56 to 61 of Lee, I'm sorry, 56 to
`61 of Dr. Condon's declaration, this is regarding Lee. I want to
`just emphasize this is where he said for five paragraphs, he
`discusses the effect of this Notice of Allowance in his
`declaration. But when presented with this in his deposition he
`said he'd never seen this before. That clearly does not meet the
`mandates of 702. That is not reliable, and then finally on 40 and
`48 of Dr. Condon's --
`JUDGE FLAX: Counsel, this is Judge Flax.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`10
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`
`MR. TUCKER: Yes.
`JUDGE FLAX: Wouldn't his declaration still be useful for
`its technological expertise? Even if the witness has admitted he
`doesn't understand patent law, can't read patent claims and really
`can't offer an opinion about whether something is legally obvious
`or anticipated, doesn't he still know plenty about eye surgery to
`give us his opinion on that?
`MR. TUCKER: I think those are some of the paragraphs
`that we're not looking to strike. The problem is when you get
`into paragraphs 87 all the way to the end of the declaration he's
`then taking that background knowledge and applying it to (audio
`interference) we're asking to get rid of. I think some of this
`commentary on what he views of the prior art, those are -- a lot
`of that's in the paragraphs that we're not looking to strike
`because he clearly is, you know, he's been practicing I believe
`it's 35 odd years and moreover, there's actually a lot of
`commentary which you'll see in our main presentation. There's a
`lot of testimony where he's confronted with what he said about
`the references, about what they teach that actually falls in
`Petitioner's favor so we're obviously not looking to strike that.
`But I think it is -- under 702 it’s completely unreliable to let
`anything related to the ultimate question in.
`Then finally 40 to 48 with Quintana is a little bit of a
`unique animal. What the argument there is is under Patent
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`11
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`Owner saying that even though Quintana was struck from the
`case that under Federal Rule of Evidence 703 that experts aren't
`allowed to consider things that are inadmissible and 703 indeed
`lets experts consider things that are inadmissible evidence like
`hearsay. But the Quintana affidavit, it's not an evidentiary issue.
`It was struck from the record from procedural grounds. It can't
`even be considered as evidence. It doesn’t exist for this case so
`703 does not apply, 703 is when you have something that's
`evidence but it's inadmissible for another reason, for instance
`hearsay. Quintana here does not exist, yet he still tried to rely
`on it. So we think that one without issue has to come out.
`So I think, Your Honor, we've laid out the specific tranches
`of his declaration that we think need to be struck or afforded
`little or no weight because it's very clear when an expert is
`opining on anticipation and obviousness and can't say what it is
`or when an expert is applying prior art to a claim and can't
`identify the claim as a method or a device, that's not reliable
`evidence under 702. So that's all I have. Thank you, Your
`Honor. Any other questions?
`JUDGE FLAX: Not for me. This is Judge Flax. If any of
`the other judges on the panel have any questions, they can ask. I
`think they don't have any. So why don't we do this. Mr. Sung,
`why don't you go ahead and take your first bit of time here and
`respond and then you can go into your motions, and then we'll
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`12
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`give Mr. Tucker a couple of minutes if he needs it to respond to
`you. Does that sound workable to everybody? You might want
`to unmute yourself, sir.
`MR. TUCKER: Yes, that works for us, Your Honor. Thank
`
`you.
`
`MR. SUNG: Yes, Your Honor, that works for Patent Owner
`as well.
`JUDGE FLAX: Okay. So why don't you respond in your
`first few minutes and then you can move into your own motion.
`MR. SUNG: Thank you, Your Honors. Good morning
`everyone. May it please the Board. Petitioner's Motion to
`Exclude portions of the Condon declaration do amount to a series
`of really deposition gotcha attempts. While taking Mr. Tucker's
`representation at face value, he's got 26 years as a patent
`litigator and Dr. Condon was trying to provide information in
`response to these questions that were rather untethered to
`particular aspects of the declaration and Dr. Condon's testimony
`and the idea that we can in our opposition respond to each one of
`those point by point is a little bit daunting.
`But at the same time, Patent Owners recognize that Dr.
`Condon is not a patent expert. He is not being put forward as a
`patent expert and to the extent he has some level of unfamiliarity
`with patent law, that does not extend to an unfamiliarity with the
`patents or the prior art. What the deposition transcript actually
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`13
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`shows is that these few instances of uncertainty do relate to
`patent claim terminology as well as aspects of the prosecution
`history and the way that the disclosure is set forward.
`However, what's even more compounded here is that
`Petitioner would like to take specific answers to specific
`questions related to one or four of the patents and extend them to
`a complete uncertainty with respect to all of the patents and let
`me give you an example of that. To the extent that Mr. Tucker is
`referring to a specific question about whether Dr. Condon
`analyzed the '155 patent other than to look at the claim language,
`Dr. Condon's answer makes sense in the context of the fact that
`the '729, the '885 and the '155 share identical specifications and
`that's the context that that answer was provided. Was it required
`that Dr. Condon go and read through each and every word of
`something that he recognized as the same specification in
`different patents, but that's the type of example that Mr. Tucker
`is relying upon. Again, looking at taking discrete answers to
`discrete statements, caveated with his level of understanding and
`lack of understanding about patent law rather than stating that he
`had not wholesale reviewed or understood particular pieces of
`evidence, including the patents and the prosecution histories.
`This is very different from whether he has provided his
`expert opinion from the perspective of a POSA in comparing the
`prior art to the challenged claims and unlike Petitioner's expert
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`14
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`Dr. Netland who repeatedly opines outside of the scope of his
`expertise about how to interpret patents, Dr. Condon was careful
`to keep his answers tied to his knowledge and experience as an
`ophthalmologist.
`With respect to the prior art, for example, Petitioner's only
`quibble is whether Dr. Condon reviewed two cited background
`references in Quintana that Dr. Condon did not recall but more
`particularly which were never raised in the petition. These two
`references were raised for the first time in the reply paper No.
`35. This too is an example of a gotcha moment that Mr. Tucker
`would like to rely on that does not undermine Dr. Condon's
`expert testimony.
`Patent Owners are happy to walk through each of these
`particular statements, questions and answers point to point but
`we are confident that if you look at the entire deposition as a
`whole there aren't statements or admissions of the inability of
`Dr. Condon to understand the technology, particularly as
`applying the prior art teachings to the claims at issue and to
`address all of the relevant points within the analysis for
`obviousness and anticipation. The idea that he is not crystal
`clear about what the law of anticipation is in the way that Mr.
`Tucker had asked him is inconsequential to his expert testimony
`for purposes of these IPRs.
`What I would also like to raise, Judge Flax, is that on our
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`15
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`prehearing call, Mr. Tucker for Petitioners had raised the issue
`about demonstratives and their concern that their objections to
`our demonstratives were based on new argument that we were
`bringing to the final hearing. Perhaps I'm mistaken but I thought
`that we might have a brief opportunity to address that aspect as
`well because I think it's very important, especially within the
`context of a video conference hearing that we can do our best to
`avoid any unnecessary interruptions during the merits argument.
`If the Board would like to address some of that we'd be happy to
`speak to it.
`JUDGE FLAX: I think that you all should address that in
`this pre-merits argument portion. But before we get to all that,
`unless you feel like you need to do it right now it sounds like
`you're ready to go into your own Motion to Exclude.
`MR. SUNG: That's correct, Your Honor.
`JUDGE FLAX: Okay. I mean, if you want to combine your
`argument over your motion and whatever you want to say about
`the demonstratives, that would be okay also.
`MR. SUNG: Yes. I think what I'd like to do if it's fine
`with the Board is to talk about our motion and then to speak
`briefly to the demonstrative issue that Mr. Tucker raised and
`then that would open up time for him to respond to all of those.
`JUDGE FLAX: Okay.
`MR. SUNG: So on Patent Owner's Motion to Exclude.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`16
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`They focus on these following key items. There are three
`exhibits that we refer to as the Netland videos. These are
`Exhibits 1031, 1032 and 1033 as well as videos related to
`something referred to as the Bang procedure. These are Exhibits
`1020 and 1021 in addition to certain paragraphs of Petitioner's
`expert report that relates to this. These particular videos and the
`declaration testimony have no permissible use in these IPRs.
`First, none of the video exhibits are prior art. These are
`post critical date evidence and the case authority relates to the
`use of post critical date evidence only in the context of showing
`inherency and that is an argument that Petitioners have not raised
`at this point in time and thus waived. Nor do these videos have
`any relevance to the prior art, particularly the Quintana reference
`because Petitioner's own expert admits that all of these
`procedures differ in material ways from Quintana, not the least
`of which is that it's not on a live patient as Dr. Quintana.
`Moreover, these exhibits have no relevance at all to Jacobi.
`Now, as a reminder the Netland videos were submitted for
`the first time in paper 35, the reply, for the sole purpose of
`rebutting the Quintana affidavit, Exhibit 2020 that was put
`forward by Patent Owners. In view of the Quintana affidavit
`having been struck by the Board, the Netland videos should be
`retroactively treated as new argument that is improperly raised in
`paper 35 that should be excluded in parallel. In particular,
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`17
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`Patent Owners have had no opportunity because of the
`introduction of these videos in the reply to rebut the Netland
`videos otherwise. Just like the absence for an opportunity for
`cross-examination of the Quintana affidavit the absence of our
`ability as Patent Owners to rebut the Netland videos is
`particularly prejudicial and the prior art, particularly Johnston - -
`JUDGE FLAX: Counsel, why do --
`MR. SUNG: -- that we will discuss in our merits argument
`
`--
`
`JUDGE FLAX: -- what are you saying, that you didn't have
`an opportunity to rebut the Netland videos? Why is that?
`MR. SUNG: The only address that we had was within the
`Motions to Exclude but the actual underlying information that
`Petitioner hoped to convey through the Netland videos, they
`submitted those videos in the reply and there were no paper
`opportunities for Patent Owners to raise a rebuttal to them. We
`had mentioned in our Motion to Exclude that we think the proper
`procedure or course would be to the extent that the Board struck
`the Quintana affidavit to similarly strike or exclude the rebuttal
`evidence to that which is in the form of these Netland videos.
`Your Honor, is there a further question?
`JUDGE FLAX: I don't know if I have another question.
`I'm just considering the fact that you had a surreply brief after
`the reply brief and you could have asked for another deposition
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`18
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`or there seemed to have been some resources at your fingertips
`that you didn't exploit, but go ahead.
`MR. SUNG: Yes, and it's Patent Owner's understanding
`that within that surreply, again, there was no opportunity to
`bring in additional evidence at that point in time and so that's the
`reason that we had addressed this in our Motion to Exclude as
`opposed to treat another or provide another paper on the
`substance of that because again, they raised it as rebuttal
`evidence to the Quintana affidavit not as any other, you know,
`not for a purpose that's tied to (audio interference) a further
`clarification of what was in the petition. So it seemed to be on a
`rather different track.
`Your Honors, if I can comment briefly on the demonstrative
`issue then before turning it over to Mr. Tucker. Mr. Tucker on
`the prehearing call had raised issues about the parties'
`demonstratives and during our meet and confer Patent Owners
`told Petitioner that the Patent Owners would lodge certain
`objections to their demonstratives on the record to preserve the
`issue but it was not a matter that Patent Owners felt required the
`Board's deliberation. However, Patent Owners do maintain the
`position that these certain slides are objectionable but, again, we
`don't believe that the Board needs to hear further about them.
`Patent Owners, on the other hand, are prepared to respond
`to each and every one of Petitioner's objections to our
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`19
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`demonstratives but the underlying assertion of new argument is
`the real issue. The demonstratives are really just a vehicle for
`that. Petitioner has advocated here for a standard whereby a
`reference to a portion of the prior art cited in the petition, the
`challenged patents or the expert witness deposition testimony
`should automatically constitute a new argument. They raised
`two cases in their objections, the IBM case and the CBS case.
`Both of these cases are readily distinguishable from the
`circumstances here.
`In those cases the focus was on a party's attempt to rely for
`the first time at oral hearing on different paragraphs of expert
`declarations that have not been previously relied upon. So none
`of these cases involve, as in oral IPRs, reliance on the prior art,
`the challenged patents or the expert witness deposition testimony
`and that's a very critical difference because as the Board knows,
`expert declarations are often written in a way that each and every
`paragraph can address a different argument and in fact in IBM
`the parties admitted that the newly cited paragraphs address
`different albeit similar arguments. Patent Owner's reference to
`the prior art, the challenged patents or any expert witness
`deposition testimony as a whole directly relates to Patent
`Owner's contention that the prior art does not teach the claimed
`inventions. The Petitioner and the Board are aware of these
`arguments in our papers and Petitioner is not prejudiced in any
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
`20
`
`

`

`IPR2020-01573 (Patent 9,107,729 B2)
`IPR2020-01711 (Patent 9,358,155 B2)
`IPR2021-00017 (Patent 9,820,885 B2)
`IPR2021-00065 (Patent 10,123,905 B2)
`IPR2021-00066 (Patent 9,999,544 B2)
`
`way by reference to what a piece of prior art as a whole
`addresses.
`Now if a party were to point -- if we were to point to a
`statement in a prior art reference to argue for the

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket